Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
- Conditions
- Breast Cancer
- First Posted Date
- 2011-04-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 12
- Registration Number
- NCT01331447
- Locations
- ๐บ๐ธ
BioKinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
- Conditions
- Breast Cancer
- First Posted Date
- 2011-04-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 47
- Registration Number
- NCT01331434
- Locations
- ๐บ๐ธ
Bio-Kinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
- Conditions
- Breast Cancer
- First Posted Date
- 2011-04-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT01331421
- Locations
- ๐บ๐ธ
BioKinetic Clinical Applications, Inc., Springfield, Missouri, United States
Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects
- First Posted Date
- 2011-03-24
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 50
- Registration Number
- NCT01322360
- Locations
- ๐บ๐ธ
Maricopa Integrated Health System, Phoenix, Arizona, United States
๐บ๐ธArkansas Children's Hospital, Little Rock, Arkansas, United States
๐บ๐ธStanford University Medical Center, Stanford, California, United States
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions
- Conditions
- Herpes
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 31
- Registration Number
- NCT01321502
- Locations
- ๐บ๐ธ
Advanced Biomedical Research, Hackensack, New Jersey, United States
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions
- Conditions
- Herpes
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 36
- Registration Number
- NCT01321515
- Locations
- ๐บ๐ธ
Advanced Biomedical Research, Inc., Hackensack, New Jersey, United States
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions
- Conditions
- Hypertension
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT01216878
- Locations
- ๐บ๐ธ
BioKinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions
- Conditions
- Hypertension
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT01216852
- Locations
- ๐บ๐ธ
Bio-Kinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 42
- Registration Number
- NCT01210638
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions
- Conditions
- Migraine
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 35
- Registration Number
- NCT01161667
- Locations
- ๐บ๐ธ
Charles River Northwest Kinetics, Tacoma, Washington, United States